Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide

Gastroenterology Research and Practice

Volumn 2017, Issue , 2017, Pages

  Scaldaferri, F ^a   Pizzoferrato, M ^a   Lopetuso, L R ^a   Musca, T ^a   Ingravalle, F ^a   Sicignano, L L ^a   Mentella, M ^a   Miggiano, G ^a   Mele, M C ^a   Gaetani, E ^a   Graziani, C ^a   Petito, V ^a   Cammarota, G ^a   Marzetti, E ^a   Martone, A ^a   Landi, F ^a   Gasbarrini, A ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; CLINICAL OUTCOME; HUMAN; INFLAMMATORY BOWEL DISEASE; MALNUTRITION; NUTRITION; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; QUALITY OF LIFE; REVIEW; SARCOPENIA;

EID: 85010284831     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2017/8646495     Document Type: Review

References (73)

1. R. Weisshof, I. Chermesh, "Micronutrient deficiencies in inflammatory bowel disease, " Current Opinion in Clinical Nutrition, Metabolic Care, vol. 18, no. 6, pp. 576-581, 2015.
2. E. Capristo, G. Mingrone, G. Addolorato, A. V. Greco, G. Gasbarrini, "Metabolic features of inflammatory bowel disease in a remission phase of the disease activity, " Journal of Internal Medicine, vol. 243, no. 5, pp. 339-347, 1998.
3. R. Rocha, G. O. Santana, N. Almeida, A. C. Lyra, "Analysis of fat, muscle mass in patients with inflammatory bowel disease during remission, active phase, " The British Journal of Nutrition, vol. 101, no. 5, pp. 676-679, 2009.
4. L. Valentini, L. Schaper, C. Buning et al. , "Malnutrition, impaired muscle strength in patients with Crohn's disease, ulcerative colitis in remission, " Nutrition, vol. 24, no. 7-8, pp. 694-702, 2008.
5. R. J. Hill, G. J. Cleghorn, G. D. Withers et al. , "Resting energy expenditure in children with inflammatory bowel disease, " Journal of Pediatric Gastroenterology, Nutrition, vol. 45, no. 3, pp. 342-346, 2007.
6. A. E. Wiskin, S. A. Wootton, T. M. Hunt et al. , "Body composition in childhood inflammatory bowel disease, " Clinical Nutrition, vol. 30, no. 1, pp. 112-115, 2011.
7. L. R. Barot, J. L. Rombeau, I. D. Feurer, J. L. Mullen, "Caloric requirements in patients with inflammatory bowel disease, " Annals of Surgery, vol. 195, no. 2, pp. 214-218, 1982.
8. X. Hébuterne, J. Filippi, R. Al-Jaouni, S. Schneider, "Nutritional consequences, nutrition therapy in Crohn's disease, " Gastroentérologie Clinique et Biologique, vol. 33, supplement 3, pp. S235-S244, 2009.
9. A. J. Lucendo, L. C. De Rezende, "Importance of nutrition in inflammatory bowel disease, "World Journal ofGastroenterology, vol. 15, no. 17, pp. 2081-2088, 2009.
10. E. Capristo, G. Addolorato, G. Mingrone, A. V. Greco, G. Gasbarrini, "Effect of disease localization on the anthropometric, metabolic features of Crohn's disease, " The American Journal of Gastroenterology, vol. 93, no. 12, pp. 2411-2419, 1998.
11. F. K. Ghishan, P. R. Kiela, "Epithelial transport in inflammatory bowel diseases, " Inflammatory Bowel Diseases, vol. 20, no. 6, pp. 1099-1109, 2014.
12. A. P. S. Urbano, L. Y. Sassaki, M. S. Dorna, M. A. B. L. Carvalhaes, L. A. Martini, A. L. A. Ferreira, "Nutritional intake according to injury extent in ulcerative colitis patients, " Journal ofHumanNutrition andDietetics, vol. 26, no. 5, pp. 445-451, 2013.
13. N. Vaisman, I. Dotan, A. Halack, E. Niv, "Malabsorption is a major contributor to underweight in Crohn's disease patients in remission, " Nutrition, vol. 22, no. 9, pp. 855-859, 2006.
14. G. Juckett, R. Trivedi, "Evaluation of chronic diarrhea, " American Family Physician, vol. 84, no. 10, pp. 1119-1126, 2011.
15. C. Hwang, V. Ross, U. Mahadevan, "Micronutrient deficiencies in inflammatory bowel disease: from A to zinc, " Inflammatory Bowel Diseases, vol. 18, no. 10, pp. 1961-1981, 2012.
16. L. R. Barot, J. L. Rombeau, J. J. Steinberg, L. O. Crosby, I. D. Feurer, J. L. Mullen, "Energy expenditure in patients with inflammatory bowel disease, " Archives of Surgery, vol. 116, no. 4, pp. 460-462, 1981.
17. A. U. Dignass, C. Gasche, D. Bettenworth et al. , "European consensus on the diagnosis, management of iron deficiency, anaemia in inflammatory bowel diseases, " Journal of Crohn's & colitis, vol. 9, no. 3, pp. 211-222, 2015.
18. R. A. Alves, S. J. Miszputen, M. S. Figueiredo, "Anemia in inflammatory bowel disease: prevalence, differential diagnosis, association with clinical, laboratory variables, " Sao Paulo Medical Journal, vol. 132, no. 3, pp. 140-146, 2014.
19. G. Weiss, C. Gasche, "Pathogenesis, treatment of anemia in inflammatory bowel disease, " Haematologica, vol. 95, no. 2, pp. 175-178, 2010.
20. G. Rogler, S. Vavricka, "Anemia in inflammatory bowel disease: an under-estimated problem" Frontiers in Medicine, vol. 1, 2015.
21. F. Bermejo, A. Algaba, I. Guerra et al. , "Should we monitor vitamin B12, folate levels in Crohn's disease patients" Scandinavian Journal of Gastroenterology, vol. 48, no. 11, pp. 1272-1277, 2013.
22. M. Yakut, Y. Ustün, G. Kabaçam, I. Soykan, "Serum vitamin B12, folate status in patients with inflammatory bowel diseases, " European Journal of Internal Medicine, vol. 21, no. 4, pp. 320-323, 2010.
23. Y. Erzin, H. Uzun, A. F. Celik, S. Aydin, A. Dirican, H. Uzunismail, "Hyperhomocysteinemia in inflammatory bowel disease patients without past intestinal resections: correlations with cobalamin, pyridoxine, folate concentrations, acute phase reactants, disease activity, prior thromboembolic complications, " Journal of Clinical Gastroenterology, vol. 42, no. 5, pp. 481-486, 2008.
24. K. Vagianos, C. N. Bernstein, "Homocysteinemia, B vitamin status among adult patients with inflammatory bowel disease: a one-year prospective follow-up study, " Inflammatory Bowel Diseases, vol. 18, no. 4, pp. 718-724, 2012.
25. J. Kong, Z. Zhang, M. W. Musch et al. , "Novel role of the vitamin Dreceptor inmaintaining the integrity of the intestinalmucosal barrier, " American Journal of Physiology-Gastrointestinal, Liver Physiology, vol. 294, no. 1, pp. G208-G216, 2008.
26. A. N. Ananthakrishnan, H. Khalili, L. M. Higuchi et al. , "Higher predicted vitamin D status is associated with reduced risk of crohn's disease, " Gastroenterology, vol. 142, no. 3, pp. 482-489, 2012.
27. R. V. Bryant, M. J. Trott, F. D. Bartholomeusz, J. M. Andrews, "Systematic review: body composition in adults with inflammatory bowel disease, " Alimentary Pharmacology & Therapeutics, vol. 38, no. 3, pp. 213-225, 2013.
28. A. J. Cruz-Jentoft, J. P. Baeyens, J. M. Bauer et al. , "Sarcopenia: European consensus on definition, diagnosis, " Age, Ageing, vol. 39, no. 4, Article IDafq034, pp. 412-423, 2010.
29. V. Santilli, A. Bernetti, M. Mangone, M. Paoloni, "Clinical definition of sarcopenia, " Clinical Cases in Mineral, Bone Metabolism, vol. 11, no. 3, pp. 177-180, 2014.
30. R. V. Bryant, S. Ooi, C. G. Schultz et al. , "Lowmusclemass, sarcopenia: common, predictive of osteopenia in inflammatory bowel disease, " Alimentary Pharmacology & Therapeutics, vol. 41, no. 9, pp. 895-906, 2015.
31. A. Flores, E. Burstein, D. J. Cipher, L. A. Feagins, "Obesity in inflammatory bowel disease: a marker of less severe disease, " Digestive Diseases, Sciences, vol. 60, no. 8, pp. 2436-2445, 2015.
32. A. Blain, S. Cattan, L. Beaugerie, F. Carbonnel, J. P. Gendre, J. Cosnes, "Crohn's disease clinical course, severity in obese patients, " Clinical Nutrition, vol. 21, pp. 51-57, 2002.
33. J. L. Seminerio, I. E. Koutroubakis, C. Ramos-Rivers et al. , "Impact of obesity on the management, clinical course of patients with inflammatory bowel disease, " Inflammatory Bowel Diseases, vol. 21, no. 12, pp. 2857-2863, 2015.
34. J. W. Harper, M. N. Sinanan, T. L. Zisman, "Increased body mass index is associated with earlier time to loss of response to infliximab in patients with inflammatory bowel disease, " Inflammatory Bowel Diseases, vol. 19, no. 10, pp. 2118-2124, 2013.
35. D. Costamagna, P. Costelli, M. Sampaolesi, F. Penna, "Role of inflammation in muscle homeostasis, myogenesis, " Mediators of Inflammation, vol. 2015, Article ID 805172, 14 pages, 2015.
36. P. Gonçalves, F. Magro, F. Martel, "Metabolic inflammation in inflammatory bowel disease: crosstalk between adipose tissue, bowel, " Inflammatory Bowel Diseases, vol. 21, no. 2, pp. 453-467, 2015.
37. S. Terzoudis, C. Zavos, I. E. Koutroubakis, "The bone, fat connection in inflammatory bowel diseases, " Inflammatory Bowel Diseases, vol. 20, no. 11, pp. 2207-2217, 2014.
38. R. C. Olney, "Regulation of bone mass by growth hormone, " Medical, PediatricOncology, vol. 41, no. 3, pp. 228-234, 2003.
39. L. M. Difedele, J. He, E. L. Bonkowski et al. , "Tumor necrosis factor blockade restores growth hormone signaling inmurine colitis, " Gastroenterology, vol. 128, no. 5, pp. 1278-1291, 2005.
40. C. Mammucari, S. Schiaffino, M. Sandri, "Downstream of Akt: FoxO3, mTOR in the regulation of autophagy in skeletal muscle, " Autophagy, vol. 4, no. 4, pp. 524-526, 2008.
41. L. A. Denson, M. A. Held, R. K. Menon, S. J. Frank, A. F. Parlow, D. L. Arnold, "Interleukin-6 inhibits hepatic growth hormone signaling via upregulation of Cis, Socs-3, " American Journal of Physiology-Gastrointestinal, Liver Physiology, vol. 284, no. 4, pp. G646-G654, 2003.
42. A. U. Trendelenburg, A. Meyer, D. Rohner, J. Boyle, S. Hatakeyama, D. J. Glass, "Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation, myotube size, " American Journal of Physiology-Cell Physiology, vol. 296, no. 6, pp. C1258-C1270, 2009.
43. R. S. Ahima, H.-K. Park, "Connecting myokines, metabolism, " Endocrinology, Metabolism, vol. 30, no. 3, pp. 235-245, 2015.
44. N. Bakkar, J. Wang, K. J. Ladner et al. , "IKK/NF-B regulates skeletal myogenesis via a signaling switch to inhibit differentiation, promote mitochondrial biogenesis, " The Journal of Cell Biology, vol. 180, no. 4, pp. 787-802, 2008.
45. E. A. Greco, A. Lenzi, S. Migliaccio, "The obesity of bone, " Therapeutic Advances in Endocrinology, Metabolism, vol. 6, no. 6, pp. 273-286, 2015.
46. R. W. Grant, V. D. Dixit, "Adipose tissue as an immunological organ, " Obesity, vol. 23, no. 3, pp. 512-518, 2015.
47. I. Olivier, V. Theódorou, P. Valet et al. , "Is Crohn's creeping fat an adipose tissue" Inflammatory Bowel Diseases, vol. 17, no. 3, pp. 747-757, 2011.
48. N. R. Borley, N. J. Mortensen, D. P. Jewell, B. F. Warren, "The relationship between inflammatory, serosal connective tissue changes in ileal Crohn's disease: evidence for a possible causative link, " Journal of Pathology, vol. 190, no. 2, pp. 196-202, 2000.
49. A. Gambero, M. Maróstica, M. J. A. Saad, J. Pedrazzoli Jr. , "Mesenteric adipose tissue alterations resulting fromexperimental reactivated colitis, " Inflammatory Bowel Diseases, vol. 13, no. 11, pp. 1357-1364, 2007.
50. G. Paul, A. Schäffler, M. Neumeier et al. , "Profiling adipocytokine secretion from creeping fat in Crohn's disease, " Inflammatory Bowel Diseases, vol. 12, no. 6, pp. 471-477, 2006.
51. G. Frühbeck, "Intracellular signalling pathways activated by leptin, " The Biochemical Journal, vol. 393, no. 1, pp. 7-20, 2006.
52. K. Karmiris, I. E. Koutroubakis, andE. A. Kouroumalis, "Leptin, adiponectin, resistin, ghrelin-implications for inflammatory bowel disease, " Molecular Nutrition & Food Research, vol. 52, no. 8, pp. 855-866, 2008.
53. X.-D. Peng, H. Xie, Q. Zhao, X.-P. Wu, Z.-Q. Sun, E.-Y. Liao, "Relationships between serum adiponectin, leptin, resistin, visfatin levels, bone mineral density, bone biochemical markers in Chinese men, " Clinica Chimica Acta, vol. 387, no. 1-2, pp. 31-35, 2008.
54. N. Silswal, A. K. Singh, B. Aruna, S. Mukhopadhyay, S. Ghosh, N. Z. Ehtesham, "Human resistin stimulates the proinflammatory cytokines TNF-, IL-12 in macrophages by NF-B-dependent pathway, " Biochemical, Biophysical Research Communications, vol. 334, no. 4, pp. 1092-1101, 2005.
55. A. Konrad, M. Lehrke, V. Schachinger et al. , "Resistin is an inflammatory marker of inflammatory bowel disease in humans, " European Journal of Gastroenterology & Hepatology, vol. 19, no. 12, pp. 1070-1074, 2007.
56. A. Fukuhara, M. Matsuda, M. Nishizawa et al. , "Visfatin: a protein secreted by visceral fat that Mimics the effects of insulin, " Science, vol. 307, no. 5708, pp. 426-430, 2005.
57. S. Han, G. Wang, S. Qiu et al. , "Increased colonic apelin production in rodents with experimental colitis, in humans with IBD, " Regulatory Peptides, vol. 142, no. 3, pp. 131-137, 2007.
58. J. E. Aubin, E. Bonnelye, "Osteoprotegerin, its ligand: a new paradigm for regulation of osteoclastogenesis, bone resorption, " MedscapeWomen's Health, vol. 5, article 5, 2000.
59. J. E. Aubin, E. Bonnelye, "Osteoprotegerin, its ligand: a new paradigm for regulation of osteoclastogenesis, bone resorption, " Osteoporosis International, vol. 11, no. 11, pp. 905-913, 2000.
60. Y.-Y. Kong, W. J. Boyle, J. M. Penninger, "Osteoprotegerin ligand: a common link between osteoclastogenesis, lymph node formation, lymphocyte development, " Immunology, Cell Biology, vol. 77, no. 2, pp. 188-193, 1999.
61. L. Thommesen, A. K. Stunes, M. Monjo et al. , "Expression, regulation of resistin in osteoblasts, osteoclasts indicate a role in bone metabolism, " Journal of Cellular Biochemistry, vol. 99, no. 3, pp. 824-834, 2006.
62. Y. Shinoda, M. Yamaguchi, N. Ogata et al. , "Regulation of bone formation by adiponectin through autocrine/paracrine, endocrine pathways, " Journal of Cellular Biochemistry, vol. 99, no. 1, pp. 196-208, 2006.
63. J. M. Miles, "Energy expenditure in hospitalized patients: implications for nutritional support, " Mayo Clinic Proceedings, vol. 81, no. 6, pp. 809-816, 2006.
64. D. D. Mijac, G. L. J. Jankovíc, J. Jorga, M. N. Krstíc, "Nutritional status in patients with active inflammatory bowel disease: prevalence of malnutrition, methods for routine nutritional assessment, " European Journal of Internal Medicine, vol. 21, no. 4, pp. 315-319, 2010.
65. D. Royall, G. R. Greenberg, J. P. Allard, J. P. Baker, J. E. Harrison, K. N. Jeejeebhoy, "Critical assessment of body-composition measurements in malnourished subjects with Crohn's disease: the role of bioelectric impedance analysis, " The American Journal of Clinical Nutrition, vol. 59, no. 2, pp. 325-330, 1994.
66. H. C. Lukaski, "Methods for the assessment of human body composition: traditional, new, " American Journal of Clinical Nutrition, vol. 46, no. 4, pp. 537-556, 1987.
67. D. R. Wagner, "Ultrasound as a tool to assess body fat, " Journal of Obesity, vol. 2013, Article ID 280713, 9 pages, 2013.
68. J. Kondrup, S. P. Allison, M. Elia, B. Vellas, M. Plauth, "ESPEN guidelines for nutrition screening 2002, " ClinicalNutrition, vol. 22, no. 4, pp. 415-421, 2003.
69. A. Sandhu, M. Mosli, B. Yan et al. , "Self-screening for malnutrition risk in outpatient inflammatory bowel disease patients using the Malnutrition Universal Screening Tool (MUST), " Journal of Parenteral, Enteral Nutrition, vol. 40, no. 4, pp. 507-510, 2016.
70. C. A. Schneider, E. Ferrannini, R. Defronzo, G. Schernthaner, J. Yates, E. Erdmann, "Effect of pioglitazone on cardiovascular outcome in diabetes, chronic kidney disease, " Journal of the American Society of Nephrology, vol. 19, no. 1, pp. 182-187, 2008.
71. J. Kondrup, H. H. Ramussen, O. Hamberg et al. , "Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials, " Clinical Nutrition, vol. 22, no. 3, pp. 321-336, 2003.
72. A. M. Beck, L. Ovesen, M. Osler, "The 'Mini Nutritional Assessment' (MNA), the 'Determine Your Nutritional Health'Checklist (NSIChecklist) as predictors ofmorbidity, mortality in an elderly Danish population, " British Journal of Nutrition, vol. 81, no. 1, pp. 31-36, 1999.
73. A. S. Detsky, J. R. McLaughlin, J. P. Baker et al. , "What is subjective global assessment of nutritional status" Journal of Parenteral, Enteral Nutrition, vol. 11, no. 1, pp. 8-13, 1987.